Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Workers' Comp
Article
What New State Health Care Proposals Could Mean for Workers' Comp and Auto
Single-payer proposals may not be changing workers’ compensation or auto medical benefits just yet, but they signal a policy direction that could a
Workers' Comp
Article
Catastrophic Claims Need a Lifetime Roadmap
Catastrophic exposure creates a different kind of pressure. You are not just paying for treatment. You are managing a lifetime problem.
Workers' Comp
Article
Building Resilience Through Crisis Intervention
Critical incidents are unusually challenging events that overwhelm usual coping.
Workers' Comp
Article
Ask The Pharmacist: What Work Comp Adjusters Should Know About New Generic Tapentadol
Is generic Nucynta IR and ER a new option for treating injured employees? Generic versions of Nucynta are now available in the U.S.
Workers' Comp
Article
How High-Performing Networks Deliver More Value
P&C leaders are feeling the mounting pressure to control overall claim spend in the face of rising medical costs, while maintaining access to c
Business Insurance
In the News